LIFE DISCOVERED. LIFE DIAGNOSED.
LIVE

Serial Number

87905886

Owner

MERIDIAN BIOSCIENCE, INC.

Attorney

J. Michael Hurst

First Use Date

Jan 1, 2018

Filing Date

May 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LIFE DISCOVERED. LIFE DIAGNOSED. Trademark

Serial Number: 87905886 • Registration: 5898110

LIFE DISCOVERED. LIFE DIAGNOSED. is a trademark filed by MERIDIAN BIOSCIENCE, INC. on May 3, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MERIDIAN BIOSCIENCE, INC. (99 trademarks)

3471 RIVER HILLS DRIVE
CINCINNATI, OH 45244

Entity Type: 03

Trademark Details

Filing Date

May 3, 2018

Registration Date

October 29, 2019

First Use Anywhere

January 1, 2018

First Use in Commerce

January 1, 2018

Published for Opposition

July 24, 2018

Goods & Services

diagnostic reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; protein in raw material form for scientific and medical research; enzymes for scientific and research purposes

medical diagnostic machines, namely, immunoassay readers used to detect and measure antigens and antibodies; medical diagnostic instruments for the analysis of body fluids; sample preparation device for medical diagnostic uses; medical diagnostic apparatus for detecting gastrointestinal diseases, viral diseases, urinary diseases, respiratory diseases, and infectious diseases

diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents; clinical medical reagents; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; enzyme preparations for medical purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 10, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 10, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 10, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 3, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 29, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 29, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 24, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 23, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 20, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 20, 2019 AITU
USE AMENDMENT FILED
Aug 27, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 27, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 19, 2019 EXRA
SOU EXTENSION 1 GRANTED
Mar 15, 2019 EX1G
SOU EXTENSION 1 FILED
Mar 15, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 15, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 18, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 4, 2018 NONP
ASSIGNED TO LIE
Jun 14, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 30, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 30, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 30, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 30, 2018 CNEA
ASSIGNED TO EXAMINER
May 29, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2018 NWOS
NEW APPLICATION ENTERED
May 7, 2018 NWAP